Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. - Wikidata - awgldk - TriplyDB

Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin.

Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin.

http://www.wikidata.org/entity/Q33853476

about

Biological response modifiers in cancer Antiangiogenic gene therapy of cancer: recent developments Microvascular complications and diabetic retinopathy: recent advances and future implications Developments in purification methods for obtaining and evaluation of collagen derived endogenous angioinhibitors Extracellular matrix as an inductive scaffold for functional tissue reconstruction Collagen XV: exploring its structure and role within the tumor microenvironment Extracellular Matrix, a Hard Player in Angiogenesis A Comprehensive View of the Structural and Functional Alterations of Extracellular Matrix by Snake Venom Metalloproteinases (SVMPs): Novel Perspectives on the Pathophysiology of Envenoming Basement membrane zone collagens XV and XVIII/proteoglycans mediate leukocyte influx in renal ischemia/reperfusion Smooth muscle cell-specific deletion of Col15a1 unexpectedly leads to impaired development of advanced atherosclerotic lesions.Epigenetic regulation of COL15A1 in smooth muscle cell replicative aging and atherosclerosis Collagen XV inhibits epithelial to mesenchymal transition in pancreatic adenocarcinoma cells.Recombinant non-collagenous domain of alpha2(IV) collagen causes involution of choroidal neovascularization by inducing apoptosis.Complete suppression of tumor formation by high levels of basement membrane collagen.Endostatin and kidney fibrosis in aging: a case for antagonistic pleiotropy?Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells.The concept of cellular "fight-or-flight" reaction to stress.Matrix metalloproteinase control of capillary morphogenesis.A potential therapeutic strategy for inhibition of ocular neovascularization with a new endogenous protein: rhEDI-8t.Decellularized allogeneic and xenogeneic tissue as a bioscaffold for regenerative medicine: factors that influence the host response.Collagens and collagen-related diseases.Lack of type XV collagen causes a skeletal myopathy and cardiovascular defects in mice.Rat mammary extracellular matrix composition and response to ibuprofen treatment during postpartum involution by differential GeLC-MS/MS analysis.New functional roles for non-collagenous domains of basement membrane collagens Cellular actions and signaling by endostatin.Specific targeting of gene expression to a subset of human trabecular meshwork cells using the chitinase 3-like 1 promoter.Molecular targets in the inhibition of angiogenesis.Recruitment of progenitor cells by an extracellular matrix cryptic peptide in a mouse model of digit amputation.Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)Biological functions of melanoma-associated antigens Regulation of matrix biology by matrix metalloproteinases.Type I collagen gene suppresses tumor growth and invasion of malignant human glioma cells Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone.Tumor suppression by collagen XV is independent of the restin domain.Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.A role for repressive complexes and H3K9 di-methylation in PRDM5-associated brittle cornea syndrome.The NC1/endostatin domain of Caenorhabditis elegans type XVIII collagen affects cell migration and axon guidance.Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers

P2860

Q24685049-9A78CD9C-F5CF-4D67-A371-0D3E11788C69 Q24803786-6EE734B2-DFF4-4726-AA03-B758DBCC14D9 Q26822476-4DF2590B-C784-4072-BD16-D2CE88761991 Q27004391-CE3B3622-7347-4F8A-888C-B4F7013F14B0 Q27006822-7C72DD68-EEFB-411F-BF0E-6EA6909D4222 Q27012955-0E78334B-4042-4474-B933-92F839A1C89B Q28072886-016F1DCA-6DD0-4648-A096-D4B49506E99A Q28077573-19F751C3-1350-4AE3-8788-564C92C13FDC Q28542782-51ABC7D5-CBEB-4E23-AD03-C372AD7BBADD Q30252988-24A494FA-B95B-4CDB-AED9-18B03E81DFB6 Q30409026-3883C64F-9020-4143-90D7-B7B7C52A1373 Q31132591-5C455A32-4B78-4D7A-A6AB-551223D87D30 Q33237435-2CAB0305-49B2-4552-8565-CFF034151599 Q33656226-5D78446F-59B3-419E-B2F0-2D47A67090A8 Q33764597-DA3D091D-7087-41DF-AD45-E510AA9628F1 Q33798648-4766FAD6-EC08-48FA-BEC5-54E3A85257CF Q33900267-59443861-56DE-4F70-A834-6CDF0D33C80F Q33938095-99516912-15F7-40F8-85A3-48D7D83D0417 Q34002149-28751A3C-D165-4E8E-A4BB-32A03E0E8247 Q34007035-C13BA585-DE44-4446-9DFE-2E46A8FA42B2 Q34039539-288E8F3A-203B-43F0-928B-9A89F4000978 Q34224267-7845CBEC-3359-4AF5-8F8C-08DD6972E2FB Q34654773-CC6EE59B-79D1-40E6-9624-7B14D72A926E Q34939050-692D3C30-F574-4BB7-A4BC-1C7D4C952DB2 Q34958987-CC8CB0CB-49D5-4BA1-B31B-012FF64000D5 Q35008096-D86A5D1E-D745-4301-8229-581C61EEAA09 Q35153678-F5C9CE5F-65A4-4F50-A684-337D26DBBBEF Q35186667-6D5782C2-F57F-4666-B2E3-54A84B277FF1 Q35230870-DC118571-56A3-4A07-ABC0-0C9E84B096A5 Q35622533-679751FE-DF7E-470F-B835-2B2715F75B74 Q35662667-1983E5E9-AA85-4B6B-95EE-AF6F98B3058B Q35819901-9BE5ED31-D5D7-4B6D-BE60-B8421C020AA9 Q35885655-4AFC3118-3ACB-419D-A7CF-15D95A5CA09A Q35902328-D5556AE5-F85A-4C0C-A92D-C6035AF7EACF Q35989215-CE774461-A578-4DD1-A641-7FC8168DF079 Q36026652-C3A88BD2-4109-455F-A8E8-8820570466F2 Q36220259-F9224C9B-DF06-42B8-BD6C-FC3A65FF789E Q36251969-B7AB2795-92C0-4A36-B216-700AD867AA1E Q36381062-F1668639-3BEE-4082-A6DA-DF66413D37D2 Q36578668-20982B27-81C2-4F64-92F5-A685685D6920

P2860

Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin.

http://www.wikidata.org/entity/Q33853476

description

1999 nî lūn-bûn

@nan

1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

name

Antiangiogenic activity of res ...... XV: comparison to endostatin.

@ast

Antiangiogenic activity of res ...... XV: comparison to endostatin.

@en

type

label

Antiangiogenic activity of res ...... XV: comparison to endostatin.

@ast

Antiangiogenic activity of res ...... XV: comparison to endostatin.

@en

prefLabel

Antiangiogenic activity of res ...... XV: comparison to endostatin.

@ast

Antiangiogenic activity of res ...... XV: comparison to endostatin.

@en

P1433

Q33853476-78896783-9887-42D6-8FCB-42AE83D618D1

P1476

Q33853476-B3F2577A-605F-4829-9881-4E809F06D0B9

P2093

Q33853476-368D080D-2B7E-44F8-A40F-840FCA4CBA77

Q33853476-4B40B9CA-A227-49E1-A870-F4CC64ADE8D3

Q33853476-55053B41-B3FE-4AA9-A9E8-A88EF04E28C5

Q33853476-5DF8B345-6C4F-489D-A375-76CED04232F2

Q33853476-804C48D9-BB65-4948-87FD-CAB7C5D8D3AD

Q33853476-8BB5DC05-D2EA-4CA5-8908-8536C866A675

Q33853476-943E1F76-60FD-4437-B72D-D555D596829C

Q33853476-CBE49478-8B52-41A5-8940-11670DBD6231

P304

Q33853476-A36BEAD4-0D98-437C-876D-747B72911047

P31

Q33853476-53C397C8-D4EE-4ED6-A7A8-D15A1195840F

P356

Q33853476-9FF08020-1290-4633-B7FF-3E06FA7F57FD

P407

Q33853476-7CB15AA8-1775-4B29-991F-960E0CA3E9F9

P433

Q33853476-49E5A76F-3C48-47C4-B72B-55D41010C376

P478

Q33853476-C0175F84-8F34-4DE3-A8D6-CA4922AC5E8A

P577

Q33853476-9AC80E08-5804-4515-8243-3DCD807B7351

P698

Q33853476-C0FDE8D1-655F-47BF-8385-3394A8FC0784

P356

P1433

Biochemical and Biophysical Research Communications

P1476

Antiangiogenic activity of res ...... XV: comparison to endostatin.

@en

P2093

Dhanabal M

http://www.w3.org/2001/XMLSchema#string

Knebelmann B

http://www.w3.org/2001/XMLSchema#string

Lu H

http://www.w3.org/2001/XMLSchema#string

Ramchandran R

http://www.w3.org/2001/XMLSchema#string

Segal M

http://www.w3.org/2001/XMLSchema#string

Sukhatme VP

http://www.w3.org/2001/XMLSchema#string

Volk R

http://www.w3.org/2001/XMLSchema#string

Waterman MJ

http://www.w3.org/2001/XMLSchema#string

P304

735-739

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1006/BBRC.1999.0248

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

255

http://www.w3.org/2001/XMLSchema#string

P577

1999-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10049780

http://www.w3.org/2001/XMLSchema#string